Chalazia are common eyelid lesions in children, resulting from chronic inflammation of sebaceous glands. Management strategies vary, but evidence specific to pediatric populations is limited.
Objectives
To review current evidence on treatment modalities for chalazia in children and propose a management algorithm.
Methods
A comprehensive literature review was conducted, synthesizing data on conservative, medical, and surgical approaches to pediatric chalazia management.
Results
Conservative treatments (warm compresses, lid hygiene) remain first-line, though pediatric-specific efficacy data is sparse. Topical antibiotics and steroids show mixed results, with potential adverse effects in children. Emerging therapies (probiotics, omega-3 supplementation, intense pulsed light) show promise but require further investigation. Intralesional steroid injections demonstrate high success rates but carry risks of rare complications. Surgical excision remains effective for persistent lesions. Tailored approaches considering underlying conditions (vitamin A deficiency, Demodex infestation, rosacea) are recommended.
Conclusions
Management of pediatric chalazia lacks standardized protocols. A tailored approach balancing efficacy and safety is crucial. Large-scale, pediatric-focused studies are needed to establish evidence-based guidelines.
LedermanCMillerM. Hordeola and chalazia. Pediatr Rev1999; 20: 283–284.
2.
KimESAfshinEEElahiE. The lowly chalazion. Surv Ophthalmol2023; 68: 784–793.
3.
ShaikhSPAzizTM. Pattern of eye diseases in children of 5-15 years at Bazzertaline Area (South Karachi) Pakistan. J Coll Physicians Surg Pak2005; 15: 291–294.
4.
AdioAOAlikorAAwoyesukuE. Survey of pediatric ophthalmic diagnoses in a teaching hospital in Nigeria. Niger J Med2011; 20: 105–108.
5.
DasAVDaveTV. Demography and clinical features of chalazion among patients seen at a multi-tier eye care network in India: an electronic medical records driven big data analysis report. Clin Ophthalmol2020; 14: 2163–2168.
6.
EvansJVoKBHSchmittM. Chalazion: racial risk factors for formation, recurrence, and surgical intervention. Can J Ophthalmol2021; 57: 242–246.
7.
RimTHKangMJChoiM, et al.Ten-year incidence and prevalence of clinically diagnosed blepharitis in South Korea: a nationwide population-based cohort study. Clin Experiment Ophthalmol2017; 45: 448–454.
8.
AmatoMPershingSWalvickM,et al.Trends in ophthalmic manifestations of methicillin-resistant Staphylococcus aureus (MRSA) in a northern California pediatric population. J AAPOS2013; 17: 243–247.
9.
Calles MonarPSJuárez MartínA. Eyelid tinea with blepharitis due to Microsporum canis. Arch Soc Esp Oftalmol2018; 93: 491–493.
10.
XiaoYGaoLShenL,et al.High load of demodex in young children with chalazia. J Pediatr Ophthalmol Strabismus2022; 60: 365–371.
11.
TarkowskiWOwczyńskaMBłaszczyk-TyszkaA,et al.Demodex mites as potential etiological factor in chalazion - a study in Poland. Acta Parasitol2015; 60: 777–783.
12.
LiangLDingXTsengSCG. High prevalence of demodex brevis infestation in chalazia. Am J Ophthalmol2013; 157: 342–348.e1.
13.
HuangJGuoM-XXiangD-M, et al.The association of demodex infestation with pediatric chalazia. BMC Ophthalmol2022; 22: 124.
14.
Molho-PessachVMeltserAKamshovA, et al.STAT1 Gain-of-function and chronic demodicosis. Pediatr Dermatol2020; 37: 153–155.
15.
Kuperman WilderLLambertiABoggioP, et al.Idiopathic aseptic facial granuloma: a retrospective study of 43 cases. Pediatr Dermatol2024; 41: 243–246.
16.
PreySEzzedineKMazereeuw-HautierJ, et al.IFAG and childhood rosacea: a possible link?Pediatr Dermatol2013; 30: 429–432.
17.
HongEFischerG. Childhood ocular rosacea: considerations for diagnosis and treatment. Australas J Dermatol2009; 50: 272–275.
18.
ZitelliKBSheilATFleckR, et al.Idiopathic facial aseptic granuloma: review of an evolving clinical entity. Pediatr Dermatol2015; 32: e136–e139.
TijaniMAlbaroudiNBoutimzineN,et al.Severe rosacea in a child. J Fr Ophtalmol2020; 43: 364–365.
21.
BamfordJTMGessertCERenierCM, et al.Childhood stye and adult rosacea. J Am Acad Dermatol2006; 55: 951–955.
22.
TangX-JLiuQChenX-K, et al.Influence of vitamin A deficiency on the transcriptomic profile of rat meibomian glands. Int Ophthalmol2021; 41: 1455–1465.
23.
ChenLChenXXiangQ, et al.Prevalence of low serum vitamin a levels in young children with chalazia in southwest China. Am J Ophthalmol2014; 157: 1103–1108.e2.
24.
ChengHLvXYaoJ,et al.Clinical report: correlation of serum vitamins and chalazion. Optom Vis Sci2022; 99: 540–543.
25.
Nieves-MorenoMGranadosMNovalS. Primary immunodeficiency diseases presenting with chalazia as the first manifestation. Ocul Immunol Inflamm2020; 29: 257–259.
26.
AgrawalVDevpuraKMishraL,et al.Study on steroid induced ocular findings in children with nephrotic syndrome. J Clin Diagn Res2017; 11: SC05–SC06.
27.
HayasakaYHayasakaSMatsukuraH. Ocular findings in Japanese children with nephrotic syndrome receiving prolonged corticosteroid therapy. Ophthalmologica2006; 220: 181–185.
Rodríguez-GarcíaAGonzález-GodínezSLópez-RubioS. Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome. Eye2015; 30: 438–446.
30.
GuptaNDhawanABeriS,et al.Clinical spectrum of pediatric blepharokeratoconjunctivitis. J AAPOS2010; 14: 527–529.
31.
SiadatiSCampbellAAMcCulleyT,et al.Clinicopathological features of 19 eyelid pilomatrixomas. Ocul Oncol Pathol2021; 8: 30–34.
32.
LloydMEagleRCWassermanBN. Pilomatrixoma masquerading as giant chalazion. Ophthalmology2018; 125: 1936.
33.
KatowitzWRShieldsCLShieldsJA, et al.Pilomatrixoma of the eyelid simulating a chalazion. J Pediatr Ophthalmol Strabismus2003; 40: 247–248.
34.
PassiNChawalaUJyotiA,et al.Pilomatrixoma of eyelid in a middle aged. Nepal J Ophthalmol2011; 3: 88–90.
35.
WaisbourdMLeibovitchISayarD,et al.Conjunctival lymphoma in a child. Cornea2011; 30: 598–599.
36.
RamRMarolfMDMarxDP, et al.Eyelid mass secondary to T-cell lymphoma in a child: a rare presentation and literature review. J Pediatr2016; 180: 282–282.e2.
37.
PapalasJAProiaADHitchcockM, et al.Neurothekeoma palpebrae: a report of 3 cases. Am J Dermatopathol2010; 32: 374–379.
38.
GrayMEPalileoCMSheridanRM. Cellular neurothekeoma of the eyelid in a 6-year-old boy. J AAPOS2016; 20: 374–376.
39.
SeeTROStålhammarGGrossniklausHE. Neurothekeoma of the eye, conjunctiva, and periorbital adnexa: a report of two cases and brief review. Surv Ophthalmol2019; 64: 852–857.
40.
WadhwaniMKursangeSSinghL,et al.An unusual presentation of a dermoid cyst mimicking a chalazion. J Pediatr Ophthalmol Strabismus2020; 57: e41–e42.
41.
CharlesNCDeMariaLNViriyaET. Osseous metaplasia of the eyelid in a child. Ophthal Plast Reconstr Surg2021; 37: e187–e188.
KarakostaCLiaskouMKattamisA, et al.Orbital rhabdomyosarcoma masquerading as a dermoid cyst: a case report and review of the literature. Cureus2023; 15: 1-6.
51.
ParkJKyungS. Unilateral primary tuberculosis presenting as an extratarsal chalazion. Can J Ophthalmol2016; 52: e1–e3.
52.
AlamSThallamMV. Primary eyelid tuberculosis mimicking as chalazion in an immunocompetent child. Orbit2019; 39: 454.
53.
NishioAKitamiYNakadaT, et al.Chalazion masquerading as sporotrichosis. J Dermatol2006; 33: 306–307.
54.
RahimiMMoinfarNAshrafiA. Eyelid leishmaniasis masquerading as chalazia. Eye2008; 23: 737.
55.
YaghoobiRMaraghiSBagheraniN,et al.Cutaneous leishmaniasis of the lid: a report of nine cases. Korean J Ophthalmol2010; 24: 40–43.
56.
MohammadpourIMotazedianMHHandjaniF,et al.Cutaneous leishmaniasis of the eyelids: a case series with molecular identification and literature review. Korean J Parasitol2016; 54: 787–792.
57.
PhuongLKConnellTMacGregorD,et al.Not just a chalazion-focal eyelid and orbital infection with Saksaenea vasiformis in an immunocompetent child. J AAPOS2022; 26: 86–89.
58.
WagnerRS. When is a chalazion not a chalazion?J Pediatr Ophthalmol Strabismus2016; 53: 205.
59.
MukhopadhyaySShomeSBarPK, et al.Ocular rhinosporidiosis presenting as recurrent chalazion. Int Ophthalmol2012; 35: 705–707.
60.
AlmeidaFATeixeira-JuniorAALPinhoJD, et al.Evaluation of diagnosed cases of eye rhinosporidiosis in a public hospital of Maranhão, Northeast Brazil. BMC Ophthalmol2019; 19: 218.
61.
MithalCAgarwalPMithalN. Ocular and adnexal rhinosporidiosis : the clinical profile and treatment outcomes in a tertiary eye care centre. Nepal J Ophthalmol2012; 4: 45–48.
62.
MologousisMAKingCSHawrylukEB. Idiopathic facial aseptic granuloma in a healthy 3-year-old girl. J Pediatr2023; 264: 113684.
63.
OzerPAGurkanA. Eyelid nodule in a child: a chalazion or idiopathic facial aseptic granuloma?Eye2014; 28: 1146–1147.
64.
ChenRLiuSTangL, et al.On the knowledge of solitary juvenile xanthogranuloma of the eyelid: a case series and literature review. Graefes Arch Clin Exp Ophthalmol2022; 260: 2339–2345.
65.
OzerPAGurkanAKurtulBE, et al.Comparative clinical outcomes of pediatric patients presenting with eyelid nodules of idiopathic facial aseptic granuloma, hordeola, and chalazia. J Pediatr Ophthalmol Strabismus2016; 53: 206–211.
66.
BagheriAHasaniHRKarimianF, et al.Effect of chalazion excision on refractive error and corneal topography. Eur J Ophthalmol2009; 19: 521–526.
67.
NemetAYVinkerSKaisermanI. Associated morbidity of chalazia. Cornea2011; 30: 1376–1381.
Brémond-GignacDNavelVDoanS,et al.Paediatric ocular rosacea: diagnosis and management with an eyelid-warming device and topical azithromycin 1.5%. J Fr Ophtalmol2022; 45: 1150–1159.
85.
JaiswalHPatidarNShahC, et al.Topical timolol 0.5% as the primary treatment of ophthalmic pyogenic granuloma: a prospective, single-arm study. Indian J Ophthalmol2021; 69: 1155–1160.
86.
ÇetinkayaAAkovaYA. Pediatric ocular acne rosacea: long-term treatment with systemic antibiotics. Am J Ophthalmol2006; 142: 816–821.
87.
YooS-ELeeD-CChangM-H. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Ophthalmol2005; 19: 258–263.
88.
GonserLIGonserCEDeuterC, et al.Systemic therapy of ocular and cutaneous rosacea in children. J Eur Acad Dermatol Venereol2017; 31: 1732–1738.
89.
GeerlingGTauberJBaudouinC, et al.The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci2011; 52: 2050–2064.
90.
VolovitzBShkapRAmirJ, et al.Absence of tooth staining with doxycycline treatment in young children. Clin Pediatr (Phila)2007; 46: 121–126.
91.
ToddSRDahlgrenFSTraegerMS, et al.No visible dental staining in children treated with doxycycline for suspected Rocky Mountain spotted fever. J Pediatr2015; 166: 1246–1251.
92.
StultzJSEilandLS. Doxycycline and tooth discoloration in children: changing of recommendations based on evidence of safety. Ann Pharmacother2019; 53: 1162–1166.
93.
KimberlinDWBarnettEDLynfieldR,et al.Tetracyclines. In: Red book: 2021-2024 report of the committee on infectious diseases. Itasca, IL: American Academy of Pediatrics, 2021, p.866.
94.
IgamiTZHolzchuhROsakiTH, et al.Oral azithromycin for treatment of posterior blepharitis. Cornea2011; 30: 1145–1149.
95.
NemetAYVinkerSKaisermanI. Associated morbidity of blepharitis. Ophthalmology2011; 118: 1062–1068.
96.
MacsaiMS. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc2008; 106: 336.
97.
ZhangXCaiYJiangY, et al.Genetic correlation between circulating metabolites and chalazion: a two-sample Mendelian randomization study. Front Mol Biosci2024; 11: 1368669.
98.
Al-NamaehM. A systematic review of the effect of omega-3 supplements on meibomian gland dysfunction. Ther Adv Ophthalmol2020; 12: 2515841420952188.
99.
GowRVHibbelnJR. Omega-3 fatty acid and nutrient deficits in adverse neurodevelopment and childhood behaviors. Child Adolesc Psychiatr Clin2014; 23: 555–590.
100.
ChangS-HChoiY. Gut dysbiosis in autoimmune diseases: association with mortality. Front Cell Infect Microbiol2023; 13: 1157918.
101.
MousaWKChehadehFHusbandS. Microbial dysbiosis in the gut drives systemic autoimmune diseases. Front Immunol2022; 13: 906258.
102.
FilippelliMdell’OmoRAmorusoA, et al.Intestinal microbiome: a new target for chalaziosis treatment in children?Eur J Pediatr2020; 180: 1293–1298.
103.
ForbesJDChenCKnoxNC, et al.A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?Microbiome2018; 6: 1–15.
104.
ElhusseinyAMFakhariHBishehsariF, et al.A gut connection in mucous membrane pemphigoid: insights into the role of the microbiome. Ocul Surf2019; 17: 615–616.
105.
JiangJYangXDuF, et al.Therapeutic effect of intense pulsed light on different types of chalazion in children. Sci Rep2024; 14: 3645.
106.
GaoXXiangQFangJ. The effect of oral vitamin A supplementation on chalazion in young children with vitamin A deficiency: a pilot study. J Ocul Pharmacol Ther2021; 37: 354–359.
107.
McCannH. Pricking the vessels: bloodletting therapy in Chinese medicine. Philadelphia, PA: Singing Dragon, 2014.
108.
QiaoHLiuNWangJ, et al.Bloodletting at EX-HN6 as an adjunctive therapy to eye drops for stye: a meta-analysis. Medicine (Baltimore)2020; 99: e21555.
109.
LeeJWYYauGSKWongMYY,et al.A comparison of intralesional triamcinolone acetonide injection for primary chalazion in children and adults. ScientificWorldJournal2014; 2014: 413729.
110.
HoSYLaiJSM. Subcutaneous steroid injection as treatment for chalazion: prospective case series. Hong Kong Med J2002; 8: 18–20.
111.
Ben SimonGJHuangLNakraT, et al.Intralesional triamcinolone acetonide injection for primary and recurrent chalazia: is it really effective?Ophthalmology2005; 112: 913–917.
112.
WongMYYYauGSKLeeJWY,et al.Intralesional triamcinolone acetonide injection for the treatment of primary chalazions. Int Ophthalmol2014; 34: 1049–1053.
113.
WongMYYauGSLeeJW,et al.Management of chalazion in pediatric patients by intralesional triamcinolone acetonide injection. Hong Kong J Ophthalmol2014; 18: 26-29.
114.
CohenBZTripathiRC. Eyelid depigmentation after intralesional injection of a fluorinated corticosteroid for chalazion. Am J Ophthalmol1979; 88: 269–270.
115.
ParkJChangM. Eyelid fat atrophy and depigmentation after an intralesional injection of triamcinolone acetonide to treat chalazion. J Craniofac Surg2017; 28: e198–e199.
116.
ThomasELLabordeRP. Retinal and choroidal vascular occlusion following intralesional corticosteroid injection of a chalazion. Ophthalmology1986; 93: 405–407.
117.
DhaliwalUBhatiaA. A rationale for therapeutic decision-making in chalazia. Orbit2005; 24: 227–230.
WesselsIFWesselsGF. Lidocaine-prilocaine cream for local-anesthesia chalazion incision in children. Ophthalmic Surg Lasers1996; 27: 431–433.
120.
NabieRSoleimaniHNikniazL, et al.A prospective randomized study comparing incision and curettage with injection of triamcinolone acetonide for chronic chalazia. J Curr Ophthalmol2019; 31: 323–326.
121.
KnezevicTIvekovicRPavicic AstalosJ, et al.Botulinum toxin A injection for primary and recurrent chalazia. Graefes Arch Clin Exp Ophthalmol2009; 247: 789–794.
WorstJGF. A new ultra-sharp loop for chalazion and cyst removal-based on the superblade principle. 1980.
126.
WuDQianTNakaoT, et al.Medically uncontrolled conjunctival pyogenic granulomas: correlation between clinical characteristics and histological findings. Oncotarget2017; 8: 2020–2024.
127.
JenningsBJ. Pyogenic granulomas. J Am Optom Assoc1987; 58: 664–673.
128.
DlaimMSBAlhusseinGAAlqahtaniRS,et al.Conservative management of giant pyogenic granuloma post strabismus surgery: a case report and literature review. Cureus2023; 15: 1-8.
129.
AlsuhaibaniAHAl-FakyYH. Large anterior orbital cyst as a late complication of chalazion surgical drainage. Eye2015; 29: 585–587.
130.
KatowitzWRO’BrienMKiskisE,et al.An asystolic event after eyelid skin bupivicaine injection during chalazion surgery. J AAPOS2016; 20: 75–77.
